Loading
A phase 1 trial of KIVU-305 run by Kivu Bioscience Inc., now recruiting.
A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors is a phase 1 interventional study registered as NCT07545356 by Kivu Bioscience Inc., with 76 participants planned, started 2026-05-25. Conditions recorded: Solid Tumors. Interventions recorded: KIVU-305.
Shares Kivu Bioscience, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Kivu Bioscience, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/